Literature DB >> 21073310

Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies.

Sheila V Graham1.   

Abstract

Human papillomaviruses (HPVs) cause diseases ranging from benign warts to invasive tumors. A subset of these viruses termed 'high risk' infect the cervix where persistent infection can lead to cervical cancer. Although many HPV genomes have been sequenced, knowledge of virus gene expression and its regulation is still incomplete. This is due in part to the lack, until recently, of suitable systems for virus propagation in the laboratory. HPV gene expression is polycistronic initiating from multiple promoters. Gene regulation occurs at transcriptional, but particularly post-transcriptional levels, including RNA processing, nuclear export, mRNA stability and translation. A close association between the virus replication cycle and epithelial differentiation adds a further layer of complexity. Understanding HPV mRNA expression and its regulation in the different diseases associated with infection may lead to development of novel diagnostic approaches and will reveal key viral and cellular targets for development of novel antiviral therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073310      PMCID: PMC3527891          DOI: 10.2217/fmb.10.107

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  106 in total

1.  Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b.

Authors:  M A Ozbun; C Meyers
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Activities of E7 promoters in the human papillomavirus type 16 genome during cell differentiation.

Authors:  Christina Neigaard Hansen; Lone Nielsen; Bodil Norrild
Journal:  Virus Res       Date:  2010-02-23       Impact factor: 3.303

3.  Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.

Authors:  A Nishimura; T Ono; A Ishimoto; J J Dowhanick; M A Frizzell; P M Howley; H Sakai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes.

Authors:  M H Stoler; S M Wolinsky; A Whitbeck; T R Broker; L T Chow
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

5.  Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region.

Authors:  Lisa Wiklund; Marcus Sokolowski; Anette Carlsson; Margaret Rush; Stefan Schwartz
Journal:  J Biol Chem       Date:  2002-07-29       Impact factor: 5.157

6.  Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules.

Authors:  Ingo Ammermann; Markus Bruckner; Frank Matthes; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

7.  The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.

Authors:  David Pim; Vjekoslav Tomaic; Lawrence Banks
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

Review 8.  Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma.

Authors:  Françoise Thierry
Journal:  Virology       Date:  2008-12-07       Impact factor: 3.616

9.  Human papillomavirus type 16 and 18 gene expression in cervical neoplasias.

Authors:  M H Stoler; C R Rhodes; A Whitbeck; S M Wolinsky; L T Chow; T R Broker
Journal:  Hum Pathol       Date:  1992-02       Impact factor: 3.466

10.  The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes.

Authors:  Michael J Lace; James R Anson; Gregory S Thomas; Lubomir P Turek; Thomas H Haugen
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

View more
  50 in total

1.  Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.

Authors:  Max A Cheng; Emily Farmer; Claire Huang; John Lin; Chien-Fu Hung; T-C Wu
Journal:  Hum Gene Ther       Date:  2018-03-16       Impact factor: 5.695

2.  Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes.

Authors:  Lanlan Wei; Anastacia M Griego; Ming Chu; Michelle A Ozbun
Journal:  Carcinogenesis       Date:  2014-07-26       Impact factor: 4.944

3.  The small splice variant of HPV16 E6, E6, reduces tumor formation in cervical carcinoma xenografts.

Authors:  Maria Filippova; Whitney Evans; Robert Aragon; Valery Filippov; Vonetta M Williams; Linda Hong; Mark E Reeves; Penelope Duerksen-Hughes
Journal:  Virology       Date:  2014-01-01       Impact factor: 3.616

Review 4.  Notch Signaling and Human Papillomavirus-Associated Oral Tumorigenesis.

Authors:  Trinath Das; Rong Zhong; Michael T Spiotto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation.

Authors:  Cecilia Johansson; Monika Somberg; Xiaoze Li; Ellenor Backström Winquist; Joanna Fay; Fergus Ryan; David Pim; Lawrence Banks; Stefan Schwartz
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

6.  HPV type 16 E6 and NFX1-123 augment JNK signaling to mediate keratinocyte differentiation and L1 expression.

Authors:  Justine Levan; Portia A Vliet-Gregg; Kristin L Robinson; Lisa R Matsumoto; Rachel A Katzenellenbogen
Journal:  Virology       Date:  2019-03-16       Impact factor: 3.616

7.  Characterization of novel transcripts of human papillomavirus type 16 using cap analysis gene expression technology.

Authors:  Ayumi Taguchi; Kazunori Nagasaka; Kei Kawana; Kosuke Hashimoto; Rika Kusumoto-Matsuo; Charles Plessy; Miranda Thomas; Hiroe Nakamura; Alessandro Bonetti; Katsutoshi Oda; Iwao Kukimoto; Piero Carninci; Lawrence Banks; Yutaka Osuga; Tomoyuki Fujii
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 8.  Role of plasmonics in detection of deadliest viruses: a review.

Authors:  Foozieh Sohrabi; Sajede Saeidifard; Masih Ghasemi; Tannaz Asadishad; Seyedeh Mehri Hamidi; Seyed Masoud Hosseini
Journal:  Eur Phys J Plus       Date:  2021-06-20       Impact factor: 3.911

9.  Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.

Authors:  T Klymenko; H Hernandez-Lopez; A I MacDonald; J M Bodily; S V Graham
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

Review 10.  Cervical Cancer Immunotherapy: Facts and Hopes.

Authors:  Louise Ferrall; Ken Y Lin; Richard B S Roden; Chien-Fu Hung; T-C Wu
Journal:  Clin Cancer Res       Date:  2021-04-22       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.